HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC for EMERGENT BIOSOLUTIONS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
Draft Departments of Labor, Health and Human Services, and Education, and related agencies' Appropriations Bill, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - P.L. 116-22; H.R. 2670 - National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Disaster Planning/Emergencies DIS
Draft Departments of Labor, Health and Human Services, and Education, and related agencies' Appropriations Bill, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - P.L. 116-22; H.R. 2670 - National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Budget/Appropriations BUD
Draft Departments of Labor, Health and Human Services, and Education, and related agencies' Appropriations Bill, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - P.L. 116-22; H.R. 2670 - National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Health Issues HCR
Draft Departments of Labor, Health and Human Services, and Education, and related agencies' Appropriations Bill, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - P.L. 116-22; H.R. 2670 - National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.